Phospho-BRCA1(S1423) Polyclonal Antibody

Phospho-BRCA1(S1423) Polyclonal Antibody

Introducing the PHOSPHO-BRCA1(S1423) Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate advanced research in the field of molecular biology. This meticulously crafted antibody is specifically engineered to target and detect the phosphorylated form of BRCA1 at serine 1423, enabling precise investigation of this critical protein's cellular functions.

With its exceptional specificity and sensitivity, the PHOSPHO-BRCA1(S1423) Polyclonal Antibody offers researchers an invaluable resource for elucidating the intricate signaling pathways involving BRCA1. By selectively binding to the phosphorylated form of BRCA1 at serine 1423, this antibody allows for accurate identification and quantification of this phosphorylation event, thereby enabling comprehensive analysis of BRCA1's role in various cellular processes.

Crafted using state-of-the-art techniques, this polyclonal antibody exhibits exceptional performance across a wide range of applications, including Western blotting, immunoprecipitation, and immunofluorescence. Its high affinity and specificity ensure reliable and reproducible results, empowering researchers to delve deeper into the intricate mechanisms underlying BRCA1's involvement in DNA repair, cell cycle regulation, and tumor suppression.

The PHOSPHO-BRCA1(S1423) Polyclonal Antibody is meticulously validated to meet the stringent quality standards demanded by the scientific community. Rigorous testing ensures its exceptional performance, reliability, and consistency, making it an indispensable tool for researchers striving to unravel the complexities of BRCA1 signaling.

In summary, the PHOSPHO-BRCA1(S1423) Polyclonal Antibody represents a breakthrough in molecular biology research, offering unparalleled specificity and sensitivity in detecting and quantifying the phosphorylated form of BRCA1 at serine 1423. With its exceptional performance and rigorous validation, this antibody empowers researchers to unlock new insights into the intricate functions of BRCA1, paving the way for advancements in cancer research and therapeutic interventions.